Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1704 | 6129 | 41.7 | 74% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
25 | 108416 | RESPIRATORY SYSTEM//CYSTIC FIBROSIS//CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1131 | 2736 | ALPHA1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ANTITRYPSIN |
2509 | 2151 | CIGARETTE SMOKE//EMPHYSEMA//LUNG BIOL DIS PROGRAM |
14026 | 733 | OXIDATIVE DAMAGE OF PROTEINS//DIPARTIMENTO AREA SERV DIAGNOST//BREATH PENTANE |
17989 | 509 | COPD RELATED PHENOTYPES//IREB2//FAM13A |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | Author keyword | 298 | 67% | 4% | 268 |
2 | ALPHA 1 ANTITRYPSIN | Author keyword | 220 | 44% | 6% | 381 |
3 | EMPHYSEMA | Author keyword | 82 | 20% | 6% | 370 |
4 | CIGARETTE SMOKE | Author keyword | 81 | 23% | 5% | 310 |
5 | ANTITRYPSIN | Author keyword | 32 | 62% | 1% | 33 |
6 | SERPIN | Author keyword | 30 | 20% | 2% | 136 |
7 | LUNG INVEST UNIT | Address | 24 | 57% | 0% | 29 |
8 | AUGMENTATION THERAPY | Author keyword | 22 | 50% | 1% | 32 |
9 | SERPINS | Author keyword | 22 | 29% | 1% | 65 |
10 | PI SUBTYPES | Author keyword | 21 | 85% | 0% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | 298 | 67% | 4% | 268 | Search ALPHA1+ANTITRYPSIN+DEFICIENCY | Search ALPHA1+ANTITRYPSIN+DEFICIENCY |
2 | ALPHA 1 ANTITRYPSIN | 220 | 44% | 6% | 381 | Search ALPHA+1+ANTITRYPSIN | Search ALPHA+1+ANTITRYPSIN |
3 | EMPHYSEMA | 82 | 20% | 6% | 370 | Search EMPHYSEMA | Search EMPHYSEMA |
4 | CIGARETTE SMOKE | 81 | 23% | 5% | 310 | Search CIGARETTE+SMOKE | Search CIGARETTE+SMOKE |
5 | ANTITRYPSIN | 32 | 62% | 1% | 33 | Search ANTITRYPSIN | Search ANTITRYPSIN |
6 | SERPIN | 30 | 20% | 2% | 136 | Search SERPIN | Search SERPIN |
7 | AUGMENTATION THERAPY | 22 | 50% | 1% | 32 | Search AUGMENTATION+THERAPY | Search AUGMENTATION+THERAPY |
8 | SERPINS | 22 | 29% | 1% | 65 | Search SERPINS | Search SERPINS |
9 | PI SUBTYPES | 21 | 85% | 0% | 11 | Search PI+SUBTYPES | Search PI+SUBTYPES |
10 | LOOP SHEET POLYMERIZATION | 20 | 100% | 0% | 9 | Search LOOP+SHEET+POLYMERIZATION | Search LOOP+SHEET+POLYMERIZATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALPHA1 ANTITRYPSIN DEFICIENCY | 659 | 57% | 13% | 785 |
2 | ALPHA 1 ANTITRYPSIN | 177 | 34% | 7% | 426 |
3 | REACTIVE LOOP | 131 | 88% | 1% | 61 |
4 | ANTITRYPSIN DEFICIENCY | 122 | 86% | 1% | 62 |
5 | SMOKE INDUCED EMPHYSEMA | 118 | 55% | 2% | 149 |
6 | EMPHYSEMA | 107 | 18% | 9% | 546 |
7 | INDUCED EMPHYSEMA | 103 | 52% | 2% | 140 |
8 | SEVERE ALPHA1 ANTITRYPSIN DEFICIENCY | 99 | 88% | 1% | 46 |
9 | ALPHA 1 PROTEINASE INHIBITOR | 98 | 30% | 5% | 280 |
10 | AUGMENTATION THERAPY | 87 | 65% | 1% | 83 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 9 | 13% | 1% | 65 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Current status of gene therapy for alpha-1 antitrypsin deficiency | 2015 | 2 | 57 | 54% |
Suspecting and Testing for Alpha-1 Antitrypsin Deficiency-An Allergist's and/or Immunologist's Perspective | 2015 | 1 | 26 | 96% |
A Review of alpha(1)-Antitrypsin Deficiency | 2012 | 61 | 143 | 84% |
MECHANISMS OF DISEASE Immunologic Aspects of Chronic Obstructive Pulmonary Disease | 2009 | 250 | 78 | 50% |
Recent advances in pre-clinical mouse models of COPD | 2014 | 17 | 102 | 55% |
Pathogenesis of chronic obstructive pulmonary disease | 2012 | 72 | 92 | 55% |
Acute-phase protein alpha 1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats | 2015 | 1 | 119 | 64% |
Immunology of asthma and chronic obstructive pulmonary disease | 2008 | 403 | 104 | 29% |
alpha 1-antitrypsin deficiency | 2005 | 223 | 91 | 85% |
Cytokine inhibition in the treatment of COPD | 2014 | 17 | 200 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUNG INVEST UNIT | 24 | 57% | 0.5% | 29 |
2 | LUNG BIOL DIS PROGRAM | 11 | 24% | 0.6% | 39 |
3 | AIRWAYS DIS SECT | 10 | 30% | 0.5% | 28 |
4 | AIRWAY DIS SECT | 10 | 25% | 0.6% | 34 |
5 | EVALUAT RISKS HUMAN REPROD | 9 | 83% | 0.1% | 5 |
6 | AD T PROJECT | 8 | 75% | 0.1% | 6 |
7 | PROT STRAIN | 8 | 100% | 0.1% | 5 |
8 | NIHR TRANSLAT IL | 7 | 56% | 0.1% | 9 |
9 | COPD GRP | 7 | 67% | 0.1% | 6 |
10 | LUNG FUNCT SLEEP | 6 | 50% | 0.1% | 9 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000042000 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |
2 | 0.0000020122 | COPD//CHRONIC OBSTRUCTIVE PULMONARY DISEASE//PULMONARY REHABILITATION |
3 | 0.0000012006 | INTERRUPTER TECHNIQUE//FORCED OSCILLATION TECHNIQUE//SPIROMETRY |
4 | 0.0000010399 | EXHALED BREATH CONDENSATE//EXHALED NITRIC OXIDE//JOURNAL OF BREATH RESEARCH |
5 | 0.0000010039 | MASPIN//RARRES3//TIG3 |
6 | 0.0000009139 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
7 | 0.0000007372 | UROKINASE RECEPTOR//FIBRINOLYSIS//PAI 1 |
8 | 0.0000006823 | BRONCHIECTASIS//PRIMARY CILIARY DYSKINESIA//MUCOCILIARY CLEARANCE |
9 | 0.0000006537 | NON NEURONAL ACETYLCHOLINE//CHOLINERGIC ANTI INFLAMMATORY PATHWAY//HEMICHOLINIUM 3 |
10 | 0.0000006471 | ASTHMA//AIRWAY SMOOTH MUSCLE//EOSINOPHILS |